Beech Hill Advisors Inc. Has $599,000 Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Beech Hill Advisors Inc. boosted its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 2.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,655 shares of the exchange traded fund’s stock after acquiring an additional 162 shares during the quarter. Beech Hill Advisors Inc.’s holdings in SPDR S&P Biotech ETF were worth $599,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in XBI. Tidemark LLC grew its position in SPDR S&P Biotech ETF by 101.5% during the 3rd quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock worth $39,000 after acquiring an additional 199 shares during the last quarter. Quintet Private Bank Europe S.A. acquired a new position in SPDR S&P Biotech ETF in the third quarter worth $40,000. ORG Wealth Partners LLC bought a new stake in shares of SPDR S&P Biotech ETF during the third quarter worth $44,000. Howe & Rusling Inc. acquired a new stake in shares of SPDR S&P Biotech ETF in the third quarter valued at $49,000. Finally, Waldron Private Wealth LLC bought a new position in shares of SPDR S&P Biotech ETF in the third quarter valued at about $54,000.

SPDR S&P Biotech ETF Stock Down 0.5 %

NYSEARCA:XBI traded down $0.42 during mid-day trading on Thursday, reaching $88.13. 648,060 shares of the company were exchanged, compared to its average volume of 8,958,191. The stock has a market cap of $6.72 billion, a PE ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 12 month low of $81.14 and a 12 month high of $105.47. The company has a fifty day moving average of $94.72 and a 200 day moving average of $97.00.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.